Price $28.37 |
Market Cap
1.48B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
9.51
|
P/S
18.34
|
Dividend %
-
|
|
P/CF
137.7
|
P/FCF
-
|
Op. Cash Flow
-13.9K
|
FCF
-0.5
|
|
Op. Margin
-23.90%
|
Net Margin
-25.40%
|
ROE
-22.70%
|
ROI
-
|
|
ROA
-18.00%
|
EPS Growth
-30.60%
|
Current Ratio
4.1
|
Debt/Equity
78.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Oncolytics Biotech, Inc. (USA) (ONCY) | $2.55 | - | - | 49.2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $3.45 | - | - | 33M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.33 | - | - | 15.9M | Strong Buy |
| Mentor Capital Inc (MNTR) | $0.59 | - | - | 15.4M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.20 | - | - | 40.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
